Metropolitan Life Insurance Company (MetLife)’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,016
| Closed | -$12.7K | – | 2411 |
|
|
2023
Q2 | $12.7K | Hold |
2,016
| – | – | ﹤0.01% | 2168 |
|
|
2023
Q1 | $11.6K | Sell |
2,016
-233
| -10% | -$1.34K | ﹤0.01% | 2101 |
|
|
2022
Q4 | $23.1K | Buy |
2,249
+222
| +11% | +$2.28K | ﹤0.01% | 1934 |
|
|
2022
Q3 | $33.9K | Hold |
2,027
| – | – | ﹤0.01% | 1723 |
|
|
2022
Q2 | $28.4K | Hold |
2,027
| – | – | ﹤0.01% | 1853 |
|
|
2022
Q1 | $32.7K | Sell |
2,027
-6,021
| -75% | -$97.2K | ﹤0.01% | 1833 |
|
|
2021
Q4 | $172K | Buy |
+8,048
| New | +$172K | ﹤0.01% | 2126 |
|